CN103301510B - 一种针灸埋植材料 - Google Patents
一种针灸埋植材料 Download PDFInfo
- Publication number
- CN103301510B CN103301510B CN201310246569.1A CN201310246569A CN103301510B CN 103301510 B CN103301510 B CN 103301510B CN 201310246569 A CN201310246569 A CN 201310246569A CN 103301510 B CN103301510 B CN 103301510B
- Authority
- CN
- China
- Prior art keywords
- acupuncture
- mixture
- implantation material
- polycaprolactone
- hexafluoroisopropanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001467 acupuncture Methods 0.000 title claims abstract description 79
- 239000000463 material Substances 0.000 title claims abstract description 63
- 238000002513 implantation Methods 0.000 title claims abstract description 43
- 229920000642 polymer Polymers 0.000 claims abstract description 24
- 238000005213 imbibition Methods 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 64
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 39
- 150000004676 glycans Chemical class 0.000 claims description 29
- 229920001282 polysaccharide Polymers 0.000 claims description 29
- 239000005017 polysaccharide Substances 0.000 claims description 29
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 24
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 19
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 229920001610 polycaprolactone Polymers 0.000 claims description 13
- 239000004632 polycaprolactone Substances 0.000 claims description 13
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 10
- 229920001285 xanthan gum Polymers 0.000 claims description 10
- 239000000230 xanthan gum Substances 0.000 claims description 10
- 229940082509 xanthan gum Drugs 0.000 claims description 10
- 229920001817 Agar Polymers 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 8
- 239000008272 agar Substances 0.000 claims description 8
- 239000000679 carrageenan Substances 0.000 claims description 8
- 229920001525 carrageenan Polymers 0.000 claims description 8
- 229940113118 carrageenan Drugs 0.000 claims description 8
- 239000000661 sodium alginate Substances 0.000 claims description 8
- 229940005550 sodium alginate Drugs 0.000 claims description 8
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 7
- 229920001503 Glucan Polymers 0.000 claims description 7
- 229920002581 Glucomannan Polymers 0.000 claims description 7
- 229920002752 Konjac Polymers 0.000 claims description 7
- 229920000881 Modified starch Polymers 0.000 claims description 7
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 7
- 229940046240 glucomannan Drugs 0.000 claims description 7
- 239000003292 glue Substances 0.000 claims description 7
- 239000000252 konjac Substances 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 5
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 5
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 5
- 241001495449 Robinia pseudoacacia Species 0.000 claims description 5
- 235000010489 acacia gum Nutrition 0.000 claims description 5
- 235000010419 agar Nutrition 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 235000010485 konjac Nutrition 0.000 claims description 5
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 5
- 235000010413 sodium alginate Nutrition 0.000 claims description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 5
- 229920002907 Guar gum Polymers 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims 4
- 230000000638 stimulation Effects 0.000 abstract description 18
- 238000011282 treatment Methods 0.000 abstract description 17
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 28
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 229960004756 ethanol Drugs 0.000 description 13
- 230000008020 evaporation Effects 0.000 description 13
- 238000001704 evaporation Methods 0.000 description 13
- 239000011148 porous material Substances 0.000 description 13
- 230000001954 sterilising effect Effects 0.000 description 13
- 238000004659 sterilization and disinfection Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 229920000954 Polyglycolide Polymers 0.000 description 10
- 239000004633 polyglycolic acid Substances 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 229920003091 Methocel™ Polymers 0.000 description 6
- 239000002729 catgut Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- PJRSUKFWFKUDTH-JWDJOUOUSA-N (2s)-6-amino-2-[[2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[(2-aminoacetyl)amino]-4-methylsulfanylbutanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]propanoyl Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O PJRSUKFWFKUDTH-JWDJOUOUSA-N 0.000 description 1
- SCRCZNMJAVGGEI-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;oxepan-2-one Chemical compound O=C1COC(=O)CO1.O=C1CCCCCO1 SCRCZNMJAVGGEI-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 240000007357 Nauclea orientalis Species 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000008025 hordeolum Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 108010021753 peptide-Gly-Leu-amide Proteins 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310246569.1A CN103301510B (zh) | 2013-06-20 | 2013-06-20 | 一种针灸埋植材料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310246569.1A CN103301510B (zh) | 2013-06-20 | 2013-06-20 | 一种针灸埋植材料 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103301510A CN103301510A (zh) | 2013-09-18 |
CN103301510B true CN103301510B (zh) | 2014-12-24 |
Family
ID=49127514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310246569.1A Active CN103301510B (zh) | 2013-06-20 | 2013-06-20 | 一种针灸埋植材料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103301510B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105536076A (zh) * | 2015-12-29 | 2016-05-04 | 吕汇川 | 一种用于穴位皮下埋植线 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2631908A1 (de) * | 1975-07-15 | 1977-02-10 | Massachusetts Inst Technology | Vernetztes polymeres |
CN1552466A (zh) * | 2003-06-03 | 2004-12-08 | 天津市久康生物工程开发有限公司 | 壳聚糖可吸收医用缝合线及其制造方法 |
WO2005025630A1 (en) * | 2003-09-10 | 2005-03-24 | Cato T Laurencin | Polymeric nanofibers for tissue engineering and drug delivery |
CN1748802A (zh) * | 2005-08-04 | 2006-03-22 | 孙文善 | 可降解材料缝合线在穴位埋植中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010511427A (ja) * | 2006-12-01 | 2010-04-15 | ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ | コラーゲン阻害剤を含む医療デバイス |
-
2013
- 2013-06-20 CN CN201310246569.1A patent/CN103301510B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2631908A1 (de) * | 1975-07-15 | 1977-02-10 | Massachusetts Inst Technology | Vernetztes polymeres |
CN1552466A (zh) * | 2003-06-03 | 2004-12-08 | 天津市久康生物工程开发有限公司 | 壳聚糖可吸收医用缝合线及其制造方法 |
WO2005025630A1 (en) * | 2003-09-10 | 2005-03-24 | Cato T Laurencin | Polymeric nanofibers for tissue engineering and drug delivery |
CN1748802A (zh) * | 2005-08-04 | 2006-03-22 | 孙文善 | 可降解材料缝合线在穴位埋植中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103301510A (zh) | 2013-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103239265B (zh) | 一种胃肠道吻合手术用的吻合器 | |
CN110494114A (zh) | 皮肤的美容外观 | |
CN102626330B (zh) | 一种用可降解生物相容材料制成的十二指肠内覆膜及应用 | |
CN104857312B (zh) | 一种防治伤口感染促进伤口愈合的中药组合物 | |
CN108778352A (zh) | 皮肤增强手术缝合线 | |
CN105310734A (zh) | 涂敷有金属的带刺缝线 | |
CN105396170A (zh) | 一种医用手术缝合线及其制备方法 | |
CN103263696B (zh) | 一种新型穴位埋线及其制备方法 | |
CN105251042A (zh) | 一种医用可吸收聚乙醇酸(pga)手术缝合线及制法 | |
CN106727687A (zh) | 一种基于远红外技术的美容保健材料及其制备方法 | |
CN103301510B (zh) | 一种针灸埋植材料 | |
CN104511055A (zh) | 可降解金属材料在制备用于穴位埋植的植入体中的应用 | |
CN105457084A (zh) | 一种可镇痛抗菌的医用缝合线及制法 | |
Zhao et al. | Progress in absorbable polymeric thread used as acupoint embedding material | |
CN105561376A (zh) | 一种促进伤口愈合的医用缝合线及其制法 | |
CN105193770B (zh) | 一种治疗深度褥疮合并骨感染的涂膜剂及其制备方法 | |
Ignatov et al. | Acupoint embedding therapy | |
CN109907979A (zh) | 皮内针及其制备方法 | |
CN105457043A (zh) | 坐骨神经结扎皮下荷瘤大鼠模型及其在用于筛选镇痛抗肿瘤药物中的应用 | |
CN101129670A (zh) | 治疗骨折的中药组合物 | |
CN105251039A (zh) | 一种医用甲壳素缝合线及制备方法 | |
CN109172516A (zh) | 一种有机光热埋线材料及其制备方法 | |
CN104435860B (zh) | 一种治疗小儿上呼吸道感染的中药制剂及制备方法 | |
CN108743707A (zh) | 一种治疗鼻炎的中药复合型药油及其制备方法 | |
RU2406478C2 (ru) | Способ пролонгированного воздействия на рефлексотерапевтические точки (филлеропунктура) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161228 Address after: 200000 Shanghai, Zhongshan North Road, No. 3663, building 319, room 358th, Patentee after: Shanghai Yatai medical instrument limited company Address before: Shanghai City, Xuhui District Hua Jing Road 200231 Lane 999 No. 61 Patentee before: Sun Wenshan |
|
DD01 | Delivery of document by public notice |
Addressee: Shanghai Yatai medical instrument limited company Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200430 Address after: 200231 No.61, Lane 999, Huajing Road, Minhang District, Shanghai Patentee after: Sun Guoqin Address before: 200000 Shanghai, Zhongshan North Road, No. 3663, building 319, room 358th, Patentee before: Shanghai Yatai medical instrument limited company |
|
TR01 | Transfer of patent right | ||
DD01 | Delivery of document by public notice |
Addressee: Sun Guoqin Document name: Notification of eligibility |
|
DD01 | Delivery of document by public notice |